Ardelyx Inc (ARDX)
8.70
+1.91
(+28.13%)
USD |
NASDAQ |
May 03, 16:00
8.70
0.00 (0.00%)
After-Hours: 20:00
Ardelyx Price: 8.70 for May 3, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 02, 2024 | 6.69 | 6.85 | 6.53 | 6.79 | 5.877M |
| May 01, 2024 | 6.45 | 6.95 | 6.41 | 6.61 | 5.798M |
| Apr 30, 2024 | 6.40 | 6.745 | 6.35 | 6.40 | 6.163M |
| Apr 29, 2024 | 6.45 | 6.54 | 6.311 | 6.46 | 4.207M |
| Apr 26, 2024 | 6.35 | 6.59 | 6.30 | 6.42 | 5.485M |
| Apr 25, 2024 | 6.29 | 6.45 | 6.23 | 6.31 | 5.172M |
| Apr 24, 2024 | 6.45 | 6.66 | 6.385 | 6.43 | 5.456M |
| Apr 23, 2024 | 6.55 | 6.72 | 6.38 | 6.39 | 3.833M |
| Apr 22, 2024 | 6.60 | 6.64 | 6.382 | 6.51 | 4.582M |
| Apr 19, 2024 | 6.39 | 6.56 | 6.27 | 6.48 | 5.644M |
| Apr 18, 2024 | 6.53 | 6.565 | 6.39 | 6.44 | 3.735M |
| Apr 17, 2024 | 6.83 | 6.84 | 6.53 | 6.55 | 3.974M |
| Apr 16, 2024 | 6.72 | 6.895 | 6.65 | 6.71 | 3.538M |
| Apr 15, 2024 | 7.07 | 7.24 | 6.75 | 6.80 | 5.733M |
| Apr 12, 2024 | 7.27 | 7.43 | 7.005 | 7.06 | 4.452M |
| Apr 11, 2024 | 7.17 | 7.41 | 6.99 | 7.37 | 5.574M |
| Apr 10, 2024 | 6.91 | 7.145 | 6.85 | 7.13 | 5.377M |
| Apr 09, 2024 | 7.39 | 7.59 | 7.115 | 7.17 | 4.418M |
| Apr 08, 2024 | 7.55 | 7.55 | 7.15 | 7.32 | 5.215M |
| Apr 05, 2024 | 7.30 | 7.87 | 7.14 | 7.50 | 7.838M |
| Apr 04, 2024 | 7.40 | 7.57 | 7.13 | 7.16 | 6.449M |
| Apr 03, 2024 | 7.23 | 7.50 | 7.125 | 7.35 | 5.988M |
| Apr 02, 2024 | 7.31 | 7.44 | 7.095 | 7.34 | 7.028M |
| Apr 01, 2024 | 7.31 | 7.45 | 7.11 | 7.41 | 5.419M |
| Mar 28, 2024 | 7.41 | 7.585 | 7.245 | 7.30 | 6.719M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.5101
Minimum
Jun 14 2022
9.74
Maximum
Feb 09 2024
4.312
Average
4.26
Median
Apr 10 2023
Price Benchmarks
| Nektar Therapeutics | 1.56 |
| Rigel Pharmaceuticals Inc | 1.19 |
| Omeros Corp | 3.72 |
| Vistagen Therapeutics Inc | 4.49 |
| Karyopharm Therapeutics Inc | 1.12 |
Price Related Metrics
| PS Ratio | 15.42 |
| Price to Book Value | 12.14 |
| Earnings Yield | -3.56% |
| Market Cap | 2.024B |